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Introduction
4 antigens, employing high-throughput screens of expressed parasite cDNAs. 71
Although prime-boost immunisation of cattle with recombinant poxviruses expressing 72 some of these antigens was found to generate specific CD8+ T cell responses, the 73 immunised animals exhibited only partial protection against parasite challenge. A 74 striking feature of the CD8+ T cells induced by this immunisation protocol is that they 75 showed poor cytotoxic activity compared to CD8+ T cells generated by immunisation 76 with live parasites, suggesting poor functional differentiation of the T cell response 77 (9). 78
Killing of target cells by CD8+ T cells is achieved by release of the contents of 79
secretory lysosomes, known as lytic granules, at the immunological synapse formed 80 upon recognition of class I MHC-bound antigenic peptides by the T cell receptor. Cell 81 killing is initiated by perforin, which creates transient pores in the membrane of the 82 target cell, facilitating uptake into the cytosol of a family of serine proteases known 83 as granzymes. Granzymes exhibit different primary substrate specificities and are 84 able to act on various cellular protein substrates to trigger programmed cell death 85 (10). Five granzymes (A, B, K, H and M) have been identified in humans; mice 86 express four of these granzymes (A, B, K and M) and 6 additional granzymes (C, E, 87 D, F, G and N) (11). We have recently shown that cattle express the same 5 88 granzymes described in humans, plus a novel granzyme (designated granzyme O) 89 (12). Granzymes have been classified into three distinct evolutionary groups, based 90 on their primary substrate specificities, namely trypsin-like (granzymes A and K), 91 chymotrypsin-like (granzymes B, H, C, E, M, D, F, G and N) and metase-like 92 (granzyme M) (13). The most extensively studied of these proteases, granzyme B, 93 cleaves aspartic acid residues. In vitro studies have demonstrated that granzyme B 94 induces target cell death by two main pathways, one involving direct proteolytic 95 5 activation of caspases (leading to DNA damage) and the other by triggering outer 96 mitochondrial membrane permeabilisation via cleavage of the pro-apoptotic protein, 97 BH3-interaction domain death agonist (Bid) (14) . The relative physiological roles of 98 these activities in vivo remain unclear, particularly in view of the potential functional 99 redundancy among the granzymes. Nevertheless, gene knockout mice deficient in 100 granzyme B have been shown to have reduced levels of CD8+ T cell-mediated 101 cytotoxicity and have increased susceptibility to some viral infections. Despite the 102 residual ability of CD8+ T cells from granzyme B-/-mice to kill target cells, they were 103 unable to induce DNA fragmentation (15). Extrapolation of findings in mice to other 104 mammalian species is also complicated by the finding of differences in protein 105 substrate specificity between murine and human granzyme B; in contrast to human 106 granzyme B, mouse granzyme B is inefficient at cleaving Bid and is therefore 107 believed to rely largely on direct activation of caspases (16). 108
In view of the potential importance of CD8+ T cell mediated cytotoxicity as an 109 effector mechanism against T. parva, the current study set out to examine the 110 biological activity of bovine granzyme B and to investigate its role in CD8+ T cell-111 mediated killing of T. parva-infected cells. The results demonstrate that granzmye B 112 plays a key role in killing of parasitized cells, that it is able to cleave Bid and that 113 killing occurs predominantly by a caspase-independent pathway. 114
115

Results
116
Establishing an in vitro assay of granzyme B activity. Bovine granzyme B cDNA 117 incorporated into the pFLAG eukaryotic expression vector ( Figure 1A) was 118 expressed in Cos-7 cells and the expressed product tested for enzymatic activity 119 6 using a substrate assay employing AC-IEPD-pNA, which contains a tetrapeptide 120 recognized specifically by human and murine granzyme B. As shown in Figure 1B , 121 the active form of Granzyme B (pFLAG-Function -with the pro-dipeptide removed) 122 displayed strong activity against the substrate, whereas the native form (pFLAG-WT) 123 and a version containing a mutation in the active tri-peptide site (pFLAG-Mutant) 124
were inactive. As a substrate-specific control, the chymotrypsin substrate Suc-GGF-125 pNA was used in the assay and no signal was detected with any of the cattle 126
granzyme B constructs. 127
To confirm the specificity of the expressed granzyme B, the enzymatic activity was 128 measured in the presence or absence of the granzyme B inhibitor AC-IEPD-CHO. 129
The specific inhibitor dramatically reduced the activity of the cattle granzyme B 130 preparation by about 4-fold, close to the background level ( Figure 1C ). The 131 substantial loss of enzymatic function indicates an effective inhibitory capacity of AC-132 IEPD-CHO for cattle granzyme B. 133
Relationship of cytotoxic activity and granzyme B transcript profiles. Analysis 134
of cDNA from T. parva-specific CD8+ T cell lines by PCR employing primers that 135 amplify transcripts for 6 defined bovine granzymes demonstrated expression of all 136 six genes, including granzyme B (Figure 2A ). The kinetics of granzyme B mRNA 137 expression were examined using a semi-quantitative PCR to determine whether 138 expression was strongly influenced by the time interval after antigenic stimulation. 139
Examination of cDNA prepared from CD8+ T cells at 2-3 day intervals, between 2 140 and 14 days after stimulation with γ-irradiated T. parva-infected cells, demonstrated 141 that near maximal levels of gene expression were achieved between 5 and 7 days 142 after antigenic stimulation, with a subsequent decline in expression ( Figure 2B and 143 C). Cells harvested 6-7 days after antigenic stimulation were used for subsequent 7 experiments. To determine whether the levels of killing by CD8+ T cells are related 145 to granzyme B and perforin mRNA expression, CD8+ T cell clones exhibiting 146 different levels of killing were analysed using a semi-quantitative PCR. Two sets of 147 cloned CD8+ T cell lines derived from different animals (641 and 011) were 148 examined; each set of lines expressed identical TCRβ chains and recognised the 149 same epitope but exhibited different levels of cytotoxic activity on autologous 150 parasitized cells ( Figure 2D ). Of the 4 clones examined from animal 641, two 151 showed no cytotoxic activity whereas the other 2 gave 28-33% killing of parasitized 152 cells. Two of the T cell clones from animal 011 gave high levels of killing (65-75%) of 153 parasitized target cells while the other two clones gave low levels of killing (<30%). with killing activity ( Figure 2F ). 158
Relationship of cytotoxic activity and level of granzyme B protein expression. 159
A series of CD8+ T cell clones specific for the same epitope in the Tp1 T. parva 160 antigen (Tp1 214-224 ) were used to examine the relationship between killing activity 161 and granzyme B protein expression. The CD8+ T cell clones showed levels of killing 162 of T. parva-infected cells ranging from 1% to 47% at an effector to target ratio of 2:1 163 ( Figure 3A ). Granzyme B activity in culture supernatants and in cell lysates of these 164 clones following incubation with infected cells was measured using the in vitro 165 substrate-specific assay established above. As shown in Figure 3A , the T cell clones 166 showed variable levels of granzyme B release following exposure to antigen-167 expressing cells (which prior assays had confirmed do not express granzyme B 168 protein, data not shown). The levels of granzyme activity in cell supernatants showed 169 8 a close correlation with the levels of granzyme protein in lysates of the respective 170 clones (r= 0.953, p< 0.0001 - Figure 3B ), indicating that the levels of enzyme 171 release reflect the cell content rather than inherent differences in rates of release 172 during degranulation. The levels of granzyme B content of the clones showed a 173 statistically significant correlation (r =0.732, p= 0.007) with the levels of cytotoxicity of 174 the T cell clones ( Figure 3C) . In conclusion, these findings reveal that Z-IETD-FMK specifically and effectively 204 blocks the activity of cattle granzyme B and inhibits killing of target cells by bovine 205 CD8+ T cells -indicating that granzyme B is an important mediator for killing of T. 206 parva infected cells. 207
Cytotoxic activity of T cells is independent of caspases, but involves activation 208
of Bid. To examine the role of caspases in cell killing, experiments were undertaken 209 to test the ability of the pan-caspase inhibitor Z-VAD-FMK and its control Z-FA-FMK 210 to block killing by two T. parva-specific CD8+ T cell clones. In contrast to previous 211 experiments in which this inhibitor was pre-incubated with effector cells (as a 212 negative control), these experiments involved pre-incubation with the target cells. 213
Cytotoxic activity of the CD8+ T cell clones was blocked by inclusion of inhibitors of 214
perforin and granzyme B (CMA and Z-IETD-FMK respectively) but was unaffected by 215 pre-incubation with Z-VAD-FMK ( Figure 5A ), confirming that killing by these clones 216 was granzyme B-dependent but demonstrating that it was independent of caspase 217 activity. In contrast, Z-VAD-FMK specifically blocked lysis of Theileria-infected cells 218 induced by the pro-apoptotic agent cisplatin (Supplementary 2), which is known to 219 mediate cytotoxicity through caspase induction. These results therefore suggest that 220 granzyme B-mediated killing of Theileria-infected cells by specific CD8+ T cells is 221 largely independent of caspases. death. Furthermore, we provided evidence that granzyme B-mediated death of 250 parasitized cells is independent of caspases, suggesting that instead the cell death 251 may be induced via activation of Bid, which we show is cleaved by bovine granzyme 252
B. 253
Granzyme B was selected for analysis in this study as it has been shown to be the 254 most potent effector molecule utilized by CD8+ T cells to kill infected cells in both 255 humans and mice. Results obtained from generation of recombinant bovine 256 granzyme B and analysis of its biological activity demonstrated many similarities to 257 its human and murine orthologues. This included evidence that processing of the 258 translated polypeptide is similar to that described for humans and mice, with deletion 259 of the dipeptide/G a prerequisite for activation of cattle as well as human and murine initially thought to be important in granzyme B-mediated cell death, studies by many 295 groups revealed that requirement for caspase activation, even in mice, isn't absolute. 296
For example, an in vitro study of mouse CD8+ T cells showed that apoptotic nuclear 297 damage induced by granule exocytosis was abrogated by the caspase inhibitor Z-298
VAD-FMK, whereas lysis of the cells was unaffected. In contrast, target cell lysis 299
induced by the pro-apoptotic drug cisplatin was specifically blocked by this inhibitor 300 (28). Similar results have been obtained in studies with purified human granzyme B; 301 caspase inhibition preventing granzyme-induced DNA damage but not cell lysis (29). 302
These observations are consistent with the results obtained in this study, which 303 showed that Z-VAD-FMK inhibited cisplatin-induced apoptosis of Theileria-infected 304 cells, but did not inhibit granzyme B-mediated cytolytic activity of cattle CD8+ T cells. The prime rationale for conducting this study was to better understand the molecular 323 mechanisms that underlie the functional capacity of T. parva-specific CD8+ T-cells. 324
The critical role that these cells play in mediating immunological protection against T. 325 parva (29) has led to considerable efforts to identify CD8 T cell target antigens for 326 use in generating novel subunit vaccines (32, 33). A number of T. parva antigens 327 recognised by CD8 T cells from immune cattle have been identified and, although 328 they have proved to be immunogenic when used in prime-boost immunisation 329
protocols, the CD8+ T-cells elicited have generally exhibited poor cytotoxicity and 330
have been demonstrated to be poorly protective upon in vivo challenge (9). 331
Understanding the discrepancy between immunogenicity and protective efficacy will 332 be critical to defining the 'correlates of protection' that can guide subsequent vaccine 333 development. Ongoing work is applying transcriptomics to address this issue, 334 however such approaches used in isolation have limitations. further investigation of these interactions in cattle is hampered by the current lack of 360 specific antibodies and biological assays to measure other bovine granzyme 361
proteins. However, this study, which provides the first description of the biological 362 activity of a member of the granzyme family in cattle, exemplifies an approach that 363 could readily be applied to study other bovine granzymes. 364
In conclusion, work described in this paper has developed molecular and flanking reverse primer (as described above) was followed by a prolonged extension 428 step to generate mutant mega fragments. 50pmol of the other flanking primer (as 429 described above) was added to the mutant templates and the PCR reaction 430 subjected to a further 25 cycles to generate full-length product containing the 431 mutation. All three bovine granzmye B cDNAs were sub-cloned into the pFLAG-432 CMV tm -5a expression vector (Sigma) and nucleotide sequencing performed by DBS 433
Genomic (Durham University). were adjusted to 1x10 6 cells/ml in PBS, pelleted and lysed by addition of 50ul of a 474 lysis buffer per ml as described above. To examine granzyme B release, aliquots of 475 1x10 6 CD8+ T cells were distributed into the wells of 96-well V-bottomed plates 476 together with 5x10 5 target cells in a total volume of 200ul phenol-red-free complete 477 media (RPMI 1640 with 5% FCS, Invitrogen,). Control wells containing effector cells 478 and medium were also included. After incubation in an atmosphere of 5% CO 2 at 479 37°C for 4h, the plates were centrifuging for 10min at 400xg and supernatants were 480 
